前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202002248284774689   整理番号:20A1001861

アポリポ蛋白質A-I濃度と冠動脈疾患リスク:メンデル無作為化研究【JST・京大機械翻訳】

Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
著者 (42件):
Karjalainen Minna K.
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
Karjalainen Minna K.
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Karjalainen Minna K.
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Holmes Michael V.
(Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK)
Holmes Michael V.
(Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK)
Holmes Michael V.
(National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospital, Oxford, UK)
Holmes Michael V.
(Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Bristol, UK)
Wang Qin
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
Wang Qin
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Wang Qin
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Wang Qin
(Systems Epidemiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia)
Anufrieva Olga
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
Anufrieva Olga
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Anufrieva Olga
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Kaehonen Mika
(Department of Clinical Physiology, Tampere University Hospital, and Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
Lehtimaeki Terho
(Department of Clinical Chemistry, Fimlab Laboratoriesand Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland)
Havulinna Aki S.
(National Institute for Health and Welfare, Helsinki, Finland)
Havulinna Aki S.
(Institute for Molecular Medicine Finland (FIMM-HiLIFE), Helsinki, Finland)
Kristiansson Kati
(National Institute for Health and Welfare, Helsinki, Finland)
Salomaa Veikko
(National Institute for Health and Welfare, Helsinki, Finland)
Perola Markus
(National Institute for Health and Welfare, Helsinki, Finland)
Perola Markus
(Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland)
Perola Markus
(Estonian Genome Center, University of Tartu, Tartu, Estonia)
Viikari Jorma S.
(Department of Medicine, University of Turku, Turku, Finland)
Viikari Jorma S.
(Division of Medicine, Turku University Hospital, Turku, Finland)
Raitakari Olli T.
(Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland)
Raitakari Olli T.
(Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland)
Raitakari Olli T.
(Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland)
Jaervelin Marjo-Riitta
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Jaervelin Marjo-Riitta
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Jaervelin Marjo-Riitta
(Unit of Primary Health Care, Oulu University Hospital, OYS, Oulu, Finland)
Jaervelin Marjo-Riitta
(Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK)
Jaervelin Marjo-Riitta
(Department of Life Sciences, College of Health and Life Sciences, Brunel University London, UK)
Ala-Korpela Mika
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
Ala-Korpela Mika
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Ala-Korpela Mika
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Ala-Korpela Mika
(NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland)
Ala-Korpela Mika
(Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, The Alfred Hospital, Monash University, Melbourne, VIC, Australia)
Kettunen Johannes
(Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland)
Kettunen Johannes
(Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland)
Kettunen Johannes
(Biocenter Oulu, University of Oulu, Oulu, Finland)
Kettunen Johannes
(National Institute for Health and Welfare, Helsinki, Finland)

資料名:
Atherosclerosis  (Atherosclerosis)

巻: 299  ページ: 56-63  発行年: 2020年 
JST資料番号: E0599B  ISSN: 0021-9150  CODEN: ATHSBL  資料種別: 逐次刊行物 (A)
記事区分: 短報  発行国: オランダ (NLD)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。